zavegepant api

Zevagepant (1337918-83-8) Vazegepant is the first intranasal CGRP-receptor antagonist developed for acute migraine treatment studies. Product Specifications Product Name: Zevagepant CAS No.: 1337918-83-8 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: CHNO Molecular Weight: 638.8 Shelf Life: 2 Years Package: 25kg/drum Product Images